Literature DB >> 592992

[Operative therapy: thrombectomy, umbrella filter, caval ligation (author's transl)].

H Denck.   

Abstract

The goals of our therapeutic trials in acute leg and pelvic vein thrombosis are to 1. Prevent embolism, 2. Salvage the limb, 3. Prevent the postthrombotic syndrome. Early surgical thrombectomy guarantees salvage of the limb in most cases; the frequency of pulmonary embolism can be significantly reduced compared to the spontaneous course and frequency of the postthrombotic syndrome. For recidivistic pulmonary embolism the umbrella filter of Mobin-Uddin, which is implanted via a transjugular pathway, is today the treatment of choice. Further embolisms are rare. For massive lung embolism, extracorporal circulation is necessary: The formerly used Trendelenburg operation is no longer justified.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 592992     DOI: 10.1007/bf01305506

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  6 in total

1.  [The temporary arteriovenous fistula on the level of the adductor canal during venous thrombectomy].

Authors:  U Brunner
Journal:  Vasa       Date:  1975       Impact factor: 1.961

Review 2.  [Surgical treatment of phlebothrombosis].

Authors:  A Senn; U Althaus
Journal:  Chirurg       Date:  1973-05       Impact factor: 0.955

3.  Caval interruption for prevention of pulmonary embolism. Long-term results of a new method.

Authors:  K Mobin-Uddin; R McLean; H Bolooki; J R Jude
Journal:  Arch Surg       Date:  1969-12

4.  Prophylaxis of pulmonary embolism. A new experimental appraoch with initial results.

Authors:  P Eichelter; W G Schenk
Journal:  Arch Surg       Date:  1968-08

5.  [Could the outcome of therapy of deep thrombophlebitis be improved with a combination of surgical thrombectomy and regional fibrinolysis?].

Authors:  B Nachbur; A Wiesmann
Journal:  Helv Chir Acta       Date:  1978-01

6.  Prevention of pulmonary embolism by inferior vena cava filters: results in 62 cases.

Authors:  V Schlosser; G Spillner; W Kaiser
Journal:  World J Surg       Date:  1977-01       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.